Pemtumomab: Difference between revisions

Jump to navigation Jump to search
WikiBot (talk | contribs)
m Protected "Pemtumomab": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))
 
WikiBot (talk | contribs)
m Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)
 
Line 26: Line 26:
}}
}}
{{SI}}
{{SI}}
{{EH}}
 


==Overview==
==Overview==
Line 36: Line 36:


{{mousemonoclonals}}
{{mousemonoclonals}}
{{SIB}}
 
[[Category:Monoclonal antibodies]]
[[Category:Monoclonal antibodies]]
[[Category:Cancer treatments]]
[[Category:Cancer treatments]]
{{WH}}
{{WH}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Latest revision as of 14:52, 20 August 2012

Template:Drugbox-mab

WikiDoc Resources for Pemtumomab

Articles

Most recent articles on Pemtumomab

Most cited articles on Pemtumomab

Review articles on Pemtumomab

Articles on Pemtumomab in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Pemtumomab

Images of Pemtumomab

Photos of Pemtumomab

Podcasts & MP3s on Pemtumomab

Videos on Pemtumomab

Evidence Based Medicine

Cochrane Collaboration on Pemtumomab

Bandolier on Pemtumomab

TRIP on Pemtumomab

Clinical Trials

Ongoing Trials on Pemtumomab at Clinical Trials.gov

Trial results on Pemtumomab

Clinical Trials on Pemtumomab at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Pemtumomab

NICE Guidance on Pemtumomab

NHS PRODIGY Guidance

FDA on Pemtumomab

CDC on Pemtumomab

Books

Books on Pemtumomab

News

Pemtumomab in the news

Be alerted to news on Pemtumomab

News trends on Pemtumomab

Commentary

Blogs on Pemtumomab

Definitions

Definitions of Pemtumomab

Patient Resources / Community

Patient resources on Pemtumomab

Discussion groups on Pemtumomab

Patient Handouts on Pemtumomab

Directions to Hospitals Treating Pemtumomab

Risk calculators and risk factors for Pemtumomab

Healthcare Provider Resources

Symptoms of Pemtumomab

Causes & Risk Factors for Pemtumomab

Diagnostic studies for Pemtumomab

Treatment of Pemtumomab

Continuing Medical Education (CME)

CME Programs on Pemtumomab

International

Pemtumomab en Espanol

Pemtumomab en Francais

Business

Pemtumomab in the Marketplace

Patents on Pemtumomab

Experimental / Informatics

List of terms related to Pemtumomab


Overview

Pemtumomab (formerly known as Theragyn) is a mouse monoclonal antibody which it's used to treat cancer.

External link


Template:Mousemonoclonals Template:WH Template:WikiDoc Sources